MEDSPELAR AS
Operating
Investering, herunder virksomhet som står i tilknytning til dette,
samt deltakelse i andre selskaper.
Investering i aksjer og verdipapirer, herunder virksomhet som står i
forbindelse med dette, samt deltakelse i andre selskaper.
Organization
- CEO
- AN
- Chairman of the board
- AN
- Years since formation
- 22 years
- since Dec 16, 2004
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 100
- 1 share class
- Total number of shareholders
- 1
- person
Financials
- Total operating income 2025
- 23,939,106
- NOK
- Annual total result 2025
- 24,016,958
- NOK
- Total equity 2025
- 24,302,469
- NOK
Last update: Jul 14, 2026
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
AN | Managing Director/CEO | 100 % directly |
Board
| Name | Role | Shares |
|---|---|---|
AN | Chairman | 100 % directly |
LK | Alternate Member | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
AN | Managing Director/CEO, Chairman | 100 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
AN | Ordinary shares | 100 | 100 % |
Shares owned by the MEDSPELAR AS
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 22,424 | 16.08 % | |
L Closed | Ordinary shares | 471,217 | 11.65 % |
| NO0012735028 | 96,018 | 7.72 % | |
| A-shares | 31,500 | 0.06 % | |
D Closed | NO0010070063 | 1 | < 0.01 % |
| NO0010112675 | 1 | < 0.01 % | |
| NO0010215684 | 1 | < 0.01 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 23,939,106 | 1,061,460 | 431,259 | 0 | 329,000 |
Annual Total Result | 24,016,958 | 1,019,706 | 390,325 | 16,359 | 372,606 |
Total assets | 24,303,369 | 8,588,582 | 8,430,812 | 8,379,669 | 8,353,511 |
Total liabilities | 900 | 5,703,071 | 5,655,008 | 5,734,190 | 5,724,390 |
Total equity | 24,302,469 | 2,885,511 | 2,775,804 | 2,645,479 | 2,629,120 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total operating income | 23,939,106 | 1,061,460 | 431,259 | 0 | 329,000 |
Total operating costs | 46,065 | 46,934 | 41,727 | 11,368 | 35,794 |
Operating result | 23,893,042 | 1,014,526 | 389,532 | -11,368 | 293,206 |
Financial income/costs | 123,916 | 5,180 | 793 | 27,727 | 79,400 |
Profit before tax | 24,016,958 | 1,019,706 | 390,325 | 16,359 | 372,606 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 | 0 |
Annual Total Result | 24,016,958 | 1,019,706 | 390,325 | 16,359 | 372,606 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
Total fixed assets | 7,601,321 | 8,468,584 | 8,333,641 | 8,333,641 | 8,182,177 |
Total current assets | 16,702,047 | 119,998 | 97,170 | 46,028 | 171,333 |
Total assets | 24,303,369 | 8,588,582 | 8,430,812 | 8,379,669 | 8,353,511 |
Short term debt | 900 | 118,856 | 70,792 | 149,975 | 140,175 |
Long term debt | 0 | 5,584,215 | 5,584,215 | 5,584,215 | 5,584,215 |
Total liabilities | 900 | 5,703,071 | 5,655,008 | 5,734,190 | 5,724,390 |
Contributed capital | 105,940 | 105,940 | 105,940 | 105,940 | 105,940 |
Retained earnings | 24,196,529 | 2,779,571 | 2,669,864 | 2,539,539 | 2,523,180 |
Total equity | 24,302,469 | 2,885,511 | 2,775,804 | 2,645,479 | 2,629,120 |
Total equity and liabilities | 24,303,369 | 8,588,582 | 8,430,812 | 8,379,669 | 8,353,511 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company